Sitemap
Vesta Peptides

Vesta Peptides

Research peptide catalog with batch documentation (HPLC/MS/COA). Research use only. vestapeptides.com

The Freezing Step in Peptide Lyophilization: How Ice Formation Shapes the Final Freeze-Dried Cake

5 min readOct 25, 2026

--

Supercooling, nucleation, annealing and collapse temperature explained for laboratory peptide freeze-drying

Press enter or click to view image in full size

Lyophilization, or freeze-drying, is how most purified peptides end up as a dry, fluffy solid rather than a solution. It is usually described in three stages: freezing, primary drying and secondary drying. The drying stages get most of the attention because they take the most time, but many of the outcomes people notice at the end, such as how the cake looks, how fast it dissolves and how much moisture it holds, are largely decided in the first few hours, during freezing.

This article focuses only on that first step: what physically happens when a peptide solution freezes, which parameters laboratories control, and how freezing choices carry through to the dried product.

Educational note: this article describes laboratory and process chemistry for research context only. It does not discuss or endorse any human use.

What freezing actually does

When an aqueous peptide solution is cooled, the goal is not simply to make it cold. The goal is to separate almost all of the water into pure ice crystals, leaving the peptide and any excipients concentrated in the spaces between them.

As ice grows, the remaining liquid becomes more and more concentrated. Eventually one of two things happens. Some solutes crystallize out at a characteristic eutectic temperature. Others, including most peptides and sugars, never crystallize. Instead, the concentrated liquid becomes so viscous that it turns into a glass. The temperature at which this maximally freeze-concentrated phase becomes a glass is called Tg prime (Tg’).

These two temperatures matter because the product must be kept below them during primary drying. If the frozen matrix warms above its critical temperature while ice is being removed, the structure can soften and flow. This is called collapse, and it shows up as a shrunken, sticky or partially melted cake.

Supercooling and ice nucleation

Water rarely freezes right at 0 °C. In a clean vial or flask it usually supercools, staying liquid well below its freezing point until ice spontaneously nucleates. The degree of supercooling is random from container to container, and it has a large effect on the result:

  • Deep supercooling leads to fast nucleation and many small ice crystals. When those crystals sublime, they leave small pores, which create higher resistance to water vapour flow and slower primary drying. Small crystals also mean a larger ice-solute interface, which some proteins and peptides tolerate less well.
  • Shallow supercooling gives fewer, larger ice crystals and therefore larger pores, which usually means faster and more uniform drying.

Because nucleation is random, vials on the same shelf can freeze differently and dry at different rates. This is one source of batch heterogeneity, and it is why controlled nucleation techniques have been developed for production freeze-dryers. Methods described in the literature include pressurizing and rapidly depressurizing the chamber, introducing an ice fog, and briefly adjusting conditions so that all containers nucleate at about the same temperature.

Freezing rate and fill depth

How fast the shelf cools, and how deep the liquid is, also shape the ice structure.

Slow shelf cooling tends to produce larger crystals and more uniform freezing across a batch. Very fast freezing, such as plunging a container into liquid nitrogen, generally produces very fine ice and small pores, which can make primary drying slower.

Get Vesta Peptides’s stories in your inbox

Join Medium for free to get updates from this writer.

Fill depth is just as important. A thick layer of frozen solution forces water vapour to travel through more dried material before it escapes, increasing resistance and drying time. In vials, practitioners often keep the fill depth modest relative to the vial size. In bench-top laboratory work, where purified peptide fractions are frequently dried in round-bottom flasks, the solution is often shell-frozen by rotating the flask in a cold bath so that it freezes as a thin layer on the inside wall. This greatly increases surface area and shortens drying.

Annealing: a controlled warm-up

Annealing means holding the frozen product at a temperature above its glass transition but below the point where it would melt, for a set period, before cooling it again. It sounds counterintuitive, but it can be useful:

  • Small ice crystals can grow at the expense of even smaller ones, a process called Ostwald ripening, which enlarges pores and speeds primary drying.
  • Crystallizing excipients, such as mannitol or glycine, are given time to crystallize completely. If they stay partly amorphous and crystallize later, during storage, they can release water or damage the cake.
  • Vial-to-vial differences caused by random nucleation are reduced.

Annealing is not always appropriate. For some formulations it adds little, and the conditions must be chosen with knowledge of the formulation’s thermal behaviour.

Press enter or click to view image in full size

Excipients and the frozen matrix

Purified research peptides are often lyophilized with no added excipients, straight from water or dilute acetic acid after HPLC. In formulated products, however, excipients are added to control the frozen state:

  • Bulking agents such as mannitol or glycine crystallize during freezing and give the cake mechanical strength, which is useful when the peptide amount is very small.
  • Amorphous stabilizers such as sucrose or trehalose remain glassy. They are thought to protect sensitive molecules during drying and storage, but they also tend to lower the collapse temperature, which affects how drying must be run.
  • Buffers need care. Some buffer salts, sodium phosphate being a well-known example, can selectively crystallize during freezing and cause large pH shifts in the remaining liquid.

How thermal properties are measured

Before designing a freezing step, laboratories typically characterize the formulation. Differential scanning calorimetry (DSC) is used to find Tg’ and eutectic events. Freeze-drying microscopy lets an analyst watch a thin frozen film dry under a microscope and see the temperature at which the structure begins to collapse. Together these give the critical temperature that the drying stages must respect.

Signs that freezing went wrong

Several defects seen at the end of a cycle can be traced back to freezing:

  • A cake that has shrunk away from the walls or shows a collapsed, glassy region at the bottom.
  • A dense crust or skin on top, sometimes linked to surface concentration effects, which slows vapour escape.
  • Large differences in appearance or residual moisture between containers dried together.
  • Meltback, where part of the product visibly melted because ice remained when the temperature rose.

Cake appearance alone does not prove quality, but it is a quick visual signal that the frozen structure behaved as expected.

Key takeaways

Freezing is the step that sets the architecture of a lyophilized peptide. Ice crystal size determines pore size, pore size governs drying speed, and the thermal properties of the freeze-concentrate set the limits for the rest of the cycle. Controlling supercooling, freezing rate, fill depth and, where appropriate, annealing gives a more uniform and predictable dried product.

The next stages, primary and secondary drying, build directly on the structure created here.

This article is for educational purposes and laboratory research context only.

--

--

Vesta Peptides
Vesta Peptides

Written by Vesta Peptides

0 followers

Research peptide catalog with batch documentation (HPLC/MS/COA). Research use only. vestapeptides.com